GlassScriptPhysician profile
Herlanders J Williams
NPI 1538160148
$617.54
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $133 · 2021: $235 · 2022: $13.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $286.78 | 2019-2021 | |
| Aspira Women'S Health INC | $98.54 | 2020-2022 | |
| Myovant Sciences INC. | $68.00 | 2021 | |
| Exeltis, USA INC. | $43.77 | 2021 | |
| Duchesnay USA Incorporated | $27.52 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.71 | 2019 | |
| Merck Sharp & Dohme LLC | $19.99 | 2020 | |
| Amag Pharmaceuticals, INC. | $19.96 | 2020 | |
| Coopersurgical, INC. | $16.05 | 2019 | |
| Boston Scientific Corporation | $15.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herlanders Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.